Improving Clinical Research and Trials Through Pharma/Advocacy Partnerships

This podcast moderated by Mary Murray, BMS and recorded at the 6th annual Patients as Partners US conference discusses Improving Clinical Research and Trials Though Effective Pharma/Advocacy Partnerships.

Topics include:

• What are the key elements that make for an effective partnership between Industry and Advocacy Groups?
• What is not getting done or being left on the table to increase partnership value?
• In relation to clinical trials what can we and what must we learn from existing experiences in patient engagement that will help provide patients with the enhanced active role they deserve?
• From an industry perspective there are generally three key decision-making points: research priority setting, design of clinical trials, and early dialogue that can benefit from vaiours levels of patient engagement - are there other valuable areas we are missing here
• From a patient advocacy group perspective in which areas should industry be improving its clinical research, trial development and planning?

Panelists include:

• Ellen Miller-Sonet, CancerCare
• Kristin Smedley, Curing Retinal Blindness Foundation
• Tiffany Westrich-Robertson, International Foundation for Autoimmune & Autoinflammatory Arthritis (IFAA)
• Keri Yale, Boehringer Ingelheim

To learn more about the 7th annual Patients as Partners US conference taking place June 29-30, 2020 in Philadelphia, PA please visit theconferenceforum.org